---
schema_version: "secwatch.filing_event.v1"
accession: "0001615219-24-000073"
form_type: "8-K"
ticker: "DCOY"
cik: "0001615219"
company_name: "Decoy Therapeutics Inc."
filed_at: "2024-08-14T23:59:59+00:00"
generated_at: "2026-05-31T09:20:18.738206+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Salarius files ATM offering prospectus supplement for up to $335,921 in common stock

## Summary
- Filed Prospectus Supplement on July 25, 2024 for at-the-market offering of up to $335,921 of common stock.
- Offering conducted under prior S-3 registration statement (File No. 333-266589) declared effective August 16, 2022.
- ATM agreement dated February 5, 2021 with Ladenburg Thalmann & Co. Inc. as sales agent.
- Legal opinion of Hogan Lovells US LLP on share validity filed as Exhibit 5.1.

## SEC filing metadata
- accession: 0001615219-24-000073
- form_type: 8-K
- ticker: DCOY
- cik: 0001615219
- company_name: Decoy Therapeutics Inc.
- filed_at: 2024-08-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1615219/000161521924000073/0001615219-24-000073-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1615219/000161521924000073/flks-20240813.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001615219-24-000073
- JSON: https://secwatch.observer/filing/0001615219-24-000073.json
- Plain text: https://secwatch.observer/filing/0001615219-24-000073.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.